Prevalence and characterization of somatic mutations in chinese aldosterone-producing adenoma patients

Medicine (United States)

Volumn 94, Issue 16, 2015, Pages

  Wang, Baojun ^a   Li, Xintao ^a   Zhang, Xu ^a   Ma, Xin ^a   Chen, Luyao ^a   Zhang, Yu ^a   Lyu, Xiangjun ^a   Tang, Yuzhe ^a   Huang, Qingbo ^a   Gao, Yu ^a   Fan, Yang ^a   Ouyang, Jinzhi ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

aldosterone; conn adenoma; hypertension; potassium channels; sodium potassium exchanging ATPase

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATP1A1 PROTEIN, HUMAN; ATP2B3 PROTEIN, HUMAN; CACNA1D PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN; MESSENGER RNA; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ATP2B3 GENE; BLOOD SAMPLING; CACNA1D GENE; CELL PROLIFERATION; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; HEK293 CELL LINE; HUMAN; HUMAN CELL; KCNJ5 GENE; MAJOR CLINICAL STUDY; MALE; MEMBRANE DEPOLARIZATION; MUTATION RATE; POINT MUTATION; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SOMATIC MUTATION; ADENOMA; AGE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOSYNTHESIS; CHINA; CULTURE TECHNIQUE; EPIDEMIOLOGY; GENE EXPRESSION PROFILING; GENETICS; HETEROZYGOTE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SEX DIFFERENCE;

ADENOMA; ADULT; AGE FACTORS; ALDOSTERONE; ASIAN CONTINENTAL ANCESTRY GROUP; CALCIUM CHANNELS, L-TYPE; CELL CULTURE TECHNIQUES; CHINA; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE EXPRESSION PROFILING; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, MESSENGER; SEX FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84929659834     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000708     Document Type: Article

References (32)

1. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
2. Plouin PF, Amar L, Chatellier G. Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant. 2004;19:774-777.
3. Choi M, Scholl UI, Yue P, et al. K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
4. Akerstrom T, Crona J, Delgado Verdugo A, et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PloS One. 2012;7:e41926.
5. Monticone S, Hattangady NG, Nishimoto K, et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab. 2012;97:E1567-1572.
6. Taguchi R, Yamada M, Nakajima Y, et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab. 2012;97:1311-1319.
7. Fernandes-Rosa FL, Williams TA, Riester A, et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension. 2014;64:354-361.
8. Boulkroun S, Beuschlein F, Rossi GP, et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension. 2012;59:592-598.
9. Azizan EA, Murthy M, Stowasser M, et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension. 2012;59:587-591.
10. Scholl UI, Nelson-Williams C, Yue P, et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A. 2012;109:2533-2538.
11. Williams TA, Monticone S, Schack VR, et al. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension. 2014;63:188-195.
12. Mulatero P. A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab. 2008;93:2972-2974.
13. Monticone S, Hattangady NG, Penton D, et al. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab. 2013;98:E1861-E1865.
14. Williams TA, Monticone S, Crudo V, et al. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension. 2012;59:833-839.
15. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440-444444e441-442.
16. Scholl UI, Goh G, Stolting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050-1054.
17. Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055-1060.
18. Omura M, Sasano H, Saito J, et al. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006;29:883-889.
19. Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J. 2007;54:487-495.
20. Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193-202.
21. Wang B, Zhang G, Ouyang J, et al. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas. Urology. 2010;76:1018 e1011-e1017.
22. Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens. 2013;31:1465-1471discussion 1471-1462.
23. Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854-2859.
24. Sy WM, Fu SN, Luk W, et al. Primary hyperaldosteronism among Chinese hypertensive patients: how are we doing in a local district in Hong Kong. Hong Kong Med J. 2012;18:193-200.
25. Funder JW. The genetic basis of primary aldosteronism. Curr Hypertens Rep. 2012;14:120-124.
26. Lu ZH, Zhu XX, Tang ZQ, et al. Female sex hormones are associated with the reduction of serum sodium and hypertension complications in patients with aldosterone-producing adenoma. Endocr J. 2013;60:1261-1268.
27. Stowasser M, Bachmann AW, Huggard PR, et al. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. J Clin Endocrinol Metab. 2000;85:2160-2166.
28. Boschitsch E, Mayerhofer S, Magometschnigg D. Hypertension in women: the role of progesterone and aldosterone. Climacteric. 2010;13:307-313.
29. Rossi GP, Cesari M, Letizia C, et al. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens. 2014;32:1514-1521discussion 1522.
30. Kitamoto T, Suematsu S, Matsuzawa Y, et al. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas. J Atheroscler Thromb. 2015;22:191-200.
31. Azizan EA, Lam BY, Newhouse SJ, et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa-and zona fasciculata-like tumors. J Clin Endocrinol Metab. 2012;97:E819-829.
32. Dibb KM, Rose T, Makary SY, et al. Molecular basis of ion selectivity, block, and rectification of the inward rectifier Kir3.1/Kir3.4 K() channel. J Biol Chem. 2003;278:49537-49548.